BSF Enterprise Plc

Equities

BSFA

GB00BHNBDQ51

Pharmaceuticals

Market Closed - London S.E. 11:35:28 2024-04-24 am EDT 5-day change 1st Jan Change
5 GBX 0.00% Intraday chart for BSF Enterprise Plc -4.76% -51.22%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BSF Enterprise Plc announced that it has received £0.09 million in funding CI
BSF Enterprise Gets Funding for Development of Cultivated Leather MT
BSF Enterprise makes progress across its alternative leather project AN
BSF Enterprise Wins £38,000 in Grant Funding from the Government Agency Innovate UK to Begin Its Project with the University of Northampton CI
BSF subsidiaries get grant funding to partner with UK universities AN
BSF Enterprise shares up as strikes collaboration pact with Ivy Farm AN
United Oil adds Jamaica expert; Vaalco makes buy AN
BSF Enterprise PLC Announces MoU with Amelie Pichard to Produce Fashion Accessory Using Lab-Grown Leather CI
BSF Enterprise to set up seperate lab-grown leather subsidiary AN
BSF Enterprise to Create New Subsidiary for Leather Business MT
EARNINGS: BSF Enterprise "making great strides", Sylvania ups earnings AN
Earnings Flash (BSFA.L) BSF ENTERPRISE Posts FY23 Loss GBX-1.59 MT
BSF Enterprise Plc Reports Earnings Results for the Full Year Ended September 30, 2023 CI
At least 3 killed, 12 injured in unrest in India's Manipur state RE
BSF Enterprise forms cultivated meat JV with CellulaRevolution AN
BSF Enterprise, CellulaRevolution to Form New Food Technology Company MT
BSF Enterprise Plc Announces Foodtech Joint Venture with CellulaREvolution Limited CI
BSF Enterprise's 3D Bio-Tissues inks deal to test Etsyl in cosmetics AN
BSF Enterprise Unit Mulls Possible Collaboration with Cosmetic Company MT
BSF Enterprise Forms New Lab-Grown Cornea Company MT
Anglo Asian to restart Gedabek operations on approval AN
BWP REIT wins Levelling Up funding to improve building safety AN
Avingtrans buys Adaptix, TPXimpact sells Questers AN
BSF Enterprise Unit Wins European Grant MT
Avation enters new lease for Airbus A320 with Cebu AN
Chart BSF Enterprise Plc
More charts
BSF Enterprise PLC is a United Kingdom-based biotechnology company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.
More about the company
  1. Stock Market
  2. Equities
  3. BSFA Stock
  4. News BSF Enterprise Plc
  5. BSF Enterprise Jumps 9% on Trading Debut on London Bourse